SCHEMBL3559345

SCHEMBL3559345

OC(c1ccncc1)c1ccc(-c2nc3ccccc3[nH]2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.69
ALDH1A1 P00352 6/20 0.69
PKN1 Q16512 1/20 0.69
PKN2 Q16513 1/20 0.69
CHEK2 O96017 4/20 0.62
NPC1 O15118 6/20 0.57
RAB9A P51151 6/20 0.57
GAA P10253 1/20 0.57
SMN1; SMN2 Q16637 5/20 0.55
HPGD P15428 3/20 0.55
TP53 P04637 2/20 0.55
HSD17B10 Q99714 2/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
GFER P55789 1/20 0.55
LDHA P00338 1/20 0.52
EPHX2 P34913 1/20 0.52
KMT2A Q03164 1/20 0.52
PKM P14618 3/20 0.51
HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5677793 0.86 CHEK2 (0.62) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL695990 0.83 KDM4E (1.00) KDM4EALDH1A1PKN1PKN2NPC1
SCHEMBL29693614 0.83 KDM4E (1.00) KDM4EALDH1A1PKN1PKN2NPC1
SCHEMBL3563890 0.82 CHEK2 (0.65) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL3567340 0.81 CHEK2 (0.67) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL3571382 0.80 CHEK2 (0.73) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL5897852 0.80 CHEK2 (0.69) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL3565757 0.80 CHEK2 (0.69) KDM4EALDH1A1PKN1PKN2CHEK2
SCHEMBL29386825 0.79 NPC1 (0.88) KDM4EALDH1A1PKN1PKN2NPC1
SCHEMBL2178266 0.79 NPC1 (0.88) KDM4EALDH1A1PKN1PKN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687639-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-30 US disclosed
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines BW CONVERTING AB (SE) 2006-11-09 US disclosed
US-7132440-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDKN1A, DDB1, TMBIM6 KDM4E 3815/4885ALDH1A1 1427/4885PKN1 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.